Tetracyclic benzamide derivatives and methods of use thereof

Details Tetracyclic benzamide derivatives and methods of use thereof Tetracyclic benzamide derivatives and methods of use thereof

2007-05-15

2007-05-15

Aulakh, Charanjit S. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S125000, C546S061000, C514S284000

Reexamination Certificate

active

10788228

ABSTRACT:
The invention relates to Tetracyclic Benzamide Derivatives; compositions comprising a Tetracyclic Benzamide Derivative; and methods for treating or preventing an inflammatory disease, a reperfusion disease, an ischemic condition, renal failure, diabetes, a diabetic complication, a vascular disease, or cancer, comprising administering to a subject in need thereof an effective amount of a Tetracyclic Benzamide Derivative.

REFERENCES:
patent: 3710795 (1973-01-01), Higuchi et al.
patent: 4113731 (1978-09-01), Winters et al.
patent: 4263304 (1981-04-01), Ishizumi et al.
patent: 4623304 (1986-11-01), Chikada
patent: 5079246 (1992-01-01), Forbes et al.
patent: 5260316 (1993-11-01), Van Duzer et al.
patent: 5262564 (1993-11-01), Kun et al.
patent: 5597831 (1997-01-01), Michalsky et al.
patent: 5710162 (1998-01-01), Okazaki et al.
patent: 5733918 (1998-03-01), Okazaki et al.
patent: 6028079 (2000-02-01), Okazaki et al.
patent: 6346535 (2002-02-01), Cotter et al.
patent: 6346536 (2002-02-01), Li et al.
patent: 6498194 (2002-12-01), Cotter et al.
patent: 6635642 (2003-10-01), Jackson et al.
patent: 6828319 (2004-12-01), Jagtap et al.
patent: 2002/0099063 (2002-07-01), Cotter et al.
patent: 2004/0039009 (2004-02-01), Jagtap et al.
patent: 2005/0261288 (2005-11-01), Jagtap et al.
patent: 2006/0019980 (2006-01-01), Szabo et al.
patent: 2349227 (2000-05-01), None
patent: 2025932 (1980-01-01), None
patent: 2003267888 (2003-09-01), None
patent: WO 93/05023 (1993-03-01), None
patent: WO 99/08680 (1999-02-01), None
patent: WO 99/11311 (1999-03-01), None
patent: WO 99/11623 (1999-03-01), None
patent: WO 99/11628 (1999-03-01), None
patent: WO 99/11644 (1999-03-01), None
patent: WO 99/11645 (1999-03-01), None
patent: WO 99/11649 (1999-03-01), None
patent: WO 99/59973 (1999-11-01), None
patent: WO 99/59975 (1999-11-01), None
patent: WO 00/21537 (2000-04-01), None
patent: WO 00/39070 (2000-07-01), None
patent: WO 00/39104 (2000-07-01), None
patent: WO 00/42040 (2000-07-01), None
patent: WO 01/12199 (2001-02-01), None
patent: WO-01/90077 (2001-11-01), None
patent: WO 02/06284 (2002-01-01), None
patent: WO-04/014862 (2004-02-01), None
patent: WO 2004/043959 (2004-05-01), None
patent: WO 2005/012524 (2005-02-01), None
patent: WO 2005/053662 (2005-06-01), None
Abdelkarim et al., Protective effects of PJ34, a novel, potent inibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke, Int. J. Mol. Med., 7:255-260, 2001.
Aldrich, p. 32, Aldrich Chemicl Company, 1992.
Ando et al., Cyclization reactions of 1,2-bis(2-cyanophenyl—propionitriles. II. Synthesis of 5-amino-4,7-dimethoxy-11H-indo[1,2-c]isoquinolin-11-one, Bull. Chem. Soc. Japan, 47:1014-17, 1974.
Bloch et al., The role of the 5′-hydroxyl group of adenosine in determining substrate specificity for adenosine deaminase, J. Med. Chem., 10(5):908-912, 1967.
Burger's Medicinal Chemistry and Drug Discovery, 5thed., vol. 1: Principles and Practice, John Wiley and Sons, Inc., pp. 975-977, 1994.
Chatterjea et al., Cyclisation of alpha-benzythomophthalic acids, Experientia, 16:439-440, 1960.
Cushman et al., Synthesis of new indeno[1,2b]isoquinolines: Cytotoxic non-camptothecin topoisomerase I inhibitors, J. Med. Chem., 43(20):3688-3698, 2000.
Dusemund et al., 5-hydroxyisoindolo[2,1b]isoquinolin-7-one: Synthesis and isomerization, Arch. Pharm (Weinheim, Ger.), 317:381-2, 1984.
Grupp et al., Protection against hypoxia-reoxygenation in the absence of poly9ADP-ribose) synthetase in isolated working hearts, J. Mol. Cell Cardiol., 31:297-303, 1999.
Hakimelahi et al., Ring Open Analogues of Adenine Nucleoside, Aminoacyl Derivatives of Cyclo- and Acyclo-nucleosides, Helvetica Chemica Acta, 70:219-231, 1987.
Hiremath et al., A New Method for the Synthesis of 6H, 11H-Indolo[3,2-c]-isoquinolin-5-ones/thiones and their Reactions, J. Heterocyc. Chem., 30(3):603-609, 1993.
Hiremath et al., Synthesis of substituted 2-(5-oxo/thioxo-1,3,4-oxadiazol-2-yl)-indoles & 2-(5-oxo/thioxo-1,3,4-oxadiazol-2-ylamino)indoles, Indian Journal of Chemistry, Section B 22B(6):571-576, 1983.
Jantzen and Robinson, Modern Pharmaceutics, 3rded., eds. Baker and Rhodes, p. 596, 1995.
Kawana et al., Nucleoside Peptides. III. The Synthesis of N-[1-(9-Adenyl)-β-D-ribofuranuronosyl] Derivatives of Certain Aminio Acids and Peptides, J. Org. Chem., 37(2):288-290, 1972.
Kirby et al., Hydride hyperconjugation in 1(3)-methylazulenes, Tetrahedron Lett., 27:1-4; 1960.
Kirby et al., 4,6,8-trimethylazulenium percholrate. Chemistry & Industry (London, UK), 1217-1218, 1960.
Lal et al., Applications of carbon-nitrogen bond cleavage reaction: A synthesis/derivisation of 11H-indeno[1,2-c]isoquinolones, Indian J. Chem., Sect. B, 38B:33-39, 1999.
Lamping et al., LPS—binding protein protects mice from septic shock caused by LPS or gram-negative bacteria, J. Clin. Invest., 101(10):2065-2071, 1998.
Mabley et al., Inhibition of poly(ADP-ribose) synthetase by gene disruption or inhibitin with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes, Br. J. Pharmacol., 133(6):909-919, 2001.
Mandir et al., A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism, J. Neurochem., 83(1):186-192, 2002.
Mandir et al., Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism, Proc. Natl. Acad. Sci. U.S. A., 96(10):5774-5779, 1999.
Morrison and Boyd, Organic Chemistry, 5thed., Allyn and Bacon, Inc., p. 179, 1987.
Ojika et al, Ptaquiloside, a Potent Carcinogen Isolated From Bracken Fern Pteridium Aquilinum Var. Latiusculum: Structure Elucidation Based On Chemical and Spectral Evidence, and Reactions with Amino Acids, Nucleosides, and Nucleotides, Tetrahedron, 43(22):5261-5274, 1987.
Parrillo, Pathogenic mechanisms of septic shock, N. Eng. J. Med., 328:1471-1477, 1993.
Southan and Szabo, Poly(ADP-ribose) polymerase inhibitors, Curr. Med. Chem., 10:321, 2003.
Strumberg et al., Synthesis of cytotoxic indenosoquinoline topolsomerase I poisons, J. Med. Chem., 42(3):446-457, 1999.
Virag et al., Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly(ADP-ribose) synthetase (PARP) activation, immunol., 94(3):345-355, 1998.
Wang et al., Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease, Ann N.Y. Acad. Sci., 991:132-139, 2003.
Wawzonek et al., Synthesis of 6-substituted-6H-indeno[1,2-c]isoquinoline-5,11-diones, Org. Prep. Proc. Int., 14:163-8, 1982.
Wawzonek et al., Preparation and reactions of 4b-acetoxy-4b,9b-dihydroindeno[2,1-a]indene-5,10-dione, Can. J. Chem., 59:2833, 1981.
Yamaguchi et al., The Synthesis of Benzofuroquinolines. IX. A Benzofuroisoquinolinone and a Benzofuroisocoumarin, J. Heterocycl. Chem., 32(2):419-423, 1995.
Yamaguchi et al., The synthesis of benzofuroquinolines. X. Some benzofuro[3,2-c]isoquinoline derivatives, J. Hetercycl. Chem., 32(5):1517-1520, 1995.
Banasik et al., Inhibitors and activators of ADP-ribosylation reactions. Mol Cell Biochem. Sep. 1994;138(1-2):185-97.
Banasik et al., Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase. J Biol Chem. Jan. 25, 1992;267(3):1569-75.
Chatterjea et al., On 4-Keto-3:4-Dihydroisocoumarin, J. Indian Chem. Society, 44(11):911-919, 1967.
Griffin et al., Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP). J Med Chem. Dec. 17, 1998;41(26):5247-56.
Hiremath et al., 1997, “Synthesis and Biological Studies of Some New Bridgehead Nitrogen Heterocycles Containing Indoloisoquinoline Nucleus”, Oriental J. of Chemistry 13 (2):173-6.
Hiremath et al., Synthesis of Substituted 7H-Indolo[2,3-c] isoquinolines, Indian J. Of Chemistry, Section B 24B(12):1235-1238, 1985.
Hiremath et al., Synthesis and Biological Evaluation of Some Substituted 5H, 6H, 7H,-Indolo[2,3-C] Isoquinolin-5-thiones and their Derivatives, Indian J. of Heterocyclic Chemistry, 3(1):37-42, 1993.
Hiremath et

Affiliated with

Also associated with

Rating

Tetracyclic benzamide derivatives and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetracyclic benzamide derivatives and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetracyclic benzamide derivatives and methods of use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3778311